No­var­tis walks away from 3rd Zol­gens­ma plant just a year af­ter leas­ing it as it piv­ots re­sources to next-gen pipeline

When No­var­tis leased a fa­cil­i­ty in Long­mont, CO just a year ago from As­traZeneca, it had big plans to ramp up man­u­fac­tur­ing for gene ther­a­py Zol­gens­ma. That was just on the heels of the AveX­is da­ta scan­dal, and now, with Zol­gens­ma sales flag­ging, No­var­tis has de­cid­ed to walk away.

No­var­tis will de­part the Long­mont site by Ju­ly at the lat­est, the com­pa­ny said in a state­ment, which will leave 400 em­ploy­ees across the fa­cil­i­ty with­out jobs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.